Home Blog Page 229

Blog

Pharma Marketing Blog

Latest

J&J Scores High in Reputation Quotient Study

Pharma Guy - December 6, 2005

Why are ED drug sales falling?

Pharma Guy - December 5, 2005

Coming Soon: Sexy eDetailing?

Pharma Guy - December 1, 2005

Jerry Hall, Women and Pharma Marketing

Pharma Guy - December 1, 2005

Merck to Shed Fat, But Not in Sales & Marketing

Pharma Guy - November 29, 2005

Sexy Reps Sell Rx Drugs

Pharma Guy - November 28, 2005

Pfizer Tries Unbranded ED DTC Ads

Pharma Guy - November 22, 2005

AstraZeneca’s Risky Proposition

Pharma Guy - November 17, 2005

WSJ Cites PM Blog as “Must Read”

Pharma Guy - November 16, 2005

Plan B FDAgate

Pharma Guy - November 15, 2005

1...228229230...241 Page 229 of 241

EDITOR PICKS

26th DTC National Conference

March 12, 2026

Informa Connect 2026 Events

January 19, 2026

FDA Pilots Are Changing Healthcare. Here’s What Pharma Marketers Should Do...

January 16, 2026

POPULAR POSTS

FDA Has Many Hurdles to Overcome in its Effort to Stem...

May 27, 2017

Advances in Genetic Medicine May Be Outpacing Some Clinicians’ Understanding, But...

December 21, 2020

Pharma Marketing News – Past Issues (2016)

January 1, 2017

RECENT POSTS

From Messaging to Meaning: Why Pharma Marketing Needs a Stronger Point...

April 17, 2026

Stopwatch with pharmaceutical products and analytics dashboard representing speed in pharma marketing

The Velocity Problem: When Pharma Marketing Moves Slower Than the Market

April 17, 2026

Pharmaceutical marketing concept showing hidden stakeholders like policymakers, media, and algorithms influencing healthcare decisions

Invisible Audiences: The Stakeholders Pharma Marketing Ignores at Its Own Risk

April 16, 2026